Search results for "OUTCOME"

showing 10 items of 5148 documents

A multidisciplinary approach to assess recovery of consciousness in a patient with moyamoya disease

2019

Abstract Introduction Moyamoya disease (MMD) meaning “hazy puff of smoke” in Japanese is a rare chronic cerebrovascular syndrome characterized by progressive stenosis and occlusion of the internal carotid arteries (ICAs) anterior cerebral arteries (ACAs), and middle cerebral arteries (MCAs). Methods Our moyamoya patient with severely impaired cognitive and motor functions underwent a specific motor and neuropsychological rehabilitative treatments to assess the recovery of consciousness. Results Results obtained showed an improvement of clinical and neuropsychological examination. These findings highlighted the importance of an intensive rehabilitation techniques used in the care of disorder…

AdultMalemedicine.medical_specialtyConsciousnessmedicine.medical_treatmentCerebral arteriesNeuropsychological Tests050105 experimental psychologyrehabilitation03 medical and health sciencesBehavioral Neuroscience0302 clinical medicinePhysical medicine and rehabilitationOcclusionmedicineHumans0501 psychology and cognitive sciencesCarotid StenosisCognitive DysfunctionMoyamoya diseasedisorders of consciousnessneuropsychological evaluationPersistent vegetative stateOriginal ResearchRehabilitationbusiness.industry05 social sciencesNeuropsychologyNeurological RehabilitationCognitionRecovery of Functionmedicine.diseaseStenosisTreatment OutcomeItalyMotor SkillsCerebral Arterial DiseasesMoyamoya Diseasebusiness030217 neurology & neurosurgeryBrain and Behavior
researchProduct

Results from two pharmacotherapy trials show alcoholic smokers were more severely alcohol dependent but less prone to relapse than alcoholic non-smok…

2007

Aims: To assess the role of smoking on treatment outcome in quitting alcoholics on the background of the priming or coping hypothesis (Rohsenow et al. , [1997][1]). Methods: Data sets of placebo treated patients of the German phase III trial of naltrexone (Gastpar et al. , [2002][2]) and of acamprosate treated patients of a German phase IV trial Soyka et al. , [2002][3]) were reanalyzed. Differences between smoking and non-smoking alcoholics were evaluated using χ2-, t - or ANOVA-tests, relapse rates using survival techniques with Cox regression. Results: Smoking alcoholics differed significantly from non-smoking alcoholics regarding sociodemographic variables (e.g. more males, more often l…

AdultMalemedicine.medical_specialtyCoping (psychology)TaurineAcamprosateNarcotic AntagonistsTemperanceComorbidityPlaceboPhase IV TrialSeverity of Illness IndexNaltrexonePharmacotherapySex FactorsRecurrenceInternal medicinemedicineOdds RatioHumansPsychiatryProportional Hazards Modelsbusiness.industryProportional hazards modelSmokingGeneral MedicineMiddle AgedNaltrexoneClinical trialAlcoholismAcamprosateTreatment OutcomeMultivariate AnalysisFemalebusinessmedicine.drugAlcohol DeterrentsAlcohol and alcoholism (Oxford, Oxfordshire)
researchProduct

Single versus double femtosecond laser pass for incomplete laser in situ keratomileusis flap in contralateral eyes: Visual and optical outcomes

2011

Purpose To evaluate visual acuity, refractive outcomes, and anterior corneal higher-order aberrations (HOAs) after myopic laser in situ keratomileusis (LASIK) with uneventful single femtosecond laser pass versus double pass performed for intraoperative suction loss. Setting Private refractive surgery center, Valencia, Spain. Design Cohort study. Methods After the LASIK flap was created with a single pass of an Intralase femtosecond laser in 1 eye and a double pass in the fellow eye, the ablation was performed with a Visx S2 laser. At 12 months, the refraction, uncorrected (UDVA) and corrected (CDVA) distance visual acuities, and anterior corneal HOAs were measured with 4.0 mm and 6.0 mm pup…

AdultMalemedicine.medical_specialtyCorneal Wavefront AberrationVisual acuitygenetic structuresCorneal Stromamedicine.medical_treatmentKeratomileusis Laser In SituVisual AcuityKeratomileusisRefraction OcularSurgical Flapslaw.inventionCohort StudiesYoung AdultlawRefractive surgeryOphthalmologyMyopiamedicineHumansDioptreRetrospective Studiesbusiness.industryLASIKMiddle AgedLaserAblationeye diseasesSensory SystemsSurgeryOphthalmologyTreatment OutcomeFemtosecondFemaleLasers ExcimerSurgerysense organsmedicine.symptombusinessJournal of Cataract and Refractive Surgery
researchProduct

Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic …

2020

<b><i>Purpose:</i></b> The coronavirus disease 2019 (COVID-19) pandemic is disrupting urology health-care worldwide. Reduced emergency room visits resulting in adverse outcomes have most recently been reported in pediatrics and cardiology. We aimed to compare patients with emergency room visits for pyelonephritis in 2019 (pre-COVID-19 era) and within the first wave of pandemic in 2020 (COVID-19 era) with regard to the number of visits and severe adverse disease outcomes. <b><i>Methods:</i></b> We performed a retrospective multicentre study comparing characteristics and outcomes of patients with pyelonephritis, excluding patients with hydroneph…

AdultMalemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Adverse outcomesUrologymedicine.medical_treatment030232 urology & nephrologyUrologyComorbiditySide effect03 medical and health sciencesYoung Adult0302 clinical medicineInformation campaignGermanyPandemicmedicineHumansHydronephrosisPandemicsStone diseaseRetrospective StudiesOutcomePyelonephritisbusiness.industrySARS-CoV-2IncidenceCOVID-19Middle Agedmedicine.diseaseNephrectomyHospitalizationCoronavirus030220 oncology & carcinogenesis2019-nCoVCollateral damageFemaleMorbiditybusinessEmergency Service HospitalResearch ArticleUrinary infectionUrologia internationalis
researchProduct

Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autogra…

2011

Contains fulltext : 95663.pdf (Publisher’s version ) (Closed access) We present results of a phase 3 randomized trial of autografting in chronic lymphocytic leukemia versus observation for responding patients after first- or second-line treatment. The primary objective was to demonstrate that autografting improves the 5-year event-free survival (EFS) from 30% to 50%. There were 223 enrolled patients, 72% men and 28% women, 83% after first and 17% after second-line treatment. Binet stages were progressive A 13%, B 67%, C 20%; at randomization, 59% were in complete remission, and 41% in less than complete remission. Patients were randomized between autografting (n = 112) and observation (n = …

AdultMalemedicine.medical_specialtyCyclophosphamidemedicine.medical_treatmentChronic lymphocytic leukemiaImmunologyHematopoietic stem cell transplantationTransplantation AutologousBiochemistryGastroenterologyInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansSurvival rateAgedbusiness.industryHazard ratioHematopoietic Stem Cell TransplantationTranslational research Immune Regulation [ONCOL 3]Cell BiologyHematologyMiddle Agedmedicine.diseaseCombined Modality TherapyLeukemia Lymphocytic Chronic B-CellSurgeryFludarabineEuropeSurvival RateTransplantationTreatment OutcomeAlemtuzumabFemalebusinessmedicine.drug
researchProduct

Cystic vestibular schwannoma: classification, management, and facial nerve outcomes.

2009

OBJECTIVE: Review of postoperative morbidity and facial nerve outcomes of cystic vestibular schwannoma (CVS) patients compared with solid vestibular schwannoma (SVS) patients and a proposal for a new CVS classification system. STUDY DESIGN: Retrospective review. SETTING: Tertiary care facility. PATIENTS: Ninety-six patients with surgically treated CVS (1998-2008). Outcomes were assessed in a subpopulation of 57 patients with greater than or equal to 1-year follow-up compared with 57 SVS patients. INTERVENTION: Fifty-six CVS patients underwent the enlarged translabyrinthine approach with transapical extension (Type I), and 1 patient underwent a transcochlear/transzygomatic approach. MAIN OUT…

AdultMalemedicine.medical_specialtyCystic vestibular schwannomaSchwannomaVestibular schwannomaPostoperative ComplicationsmedicineHumansCystCranial Nerve NeoplasmsFacial nerve outcomesAgedRetrospective StudiesAged 80 and overTranslabyrinthine approachbusiness.industryCystsAcoustic neuromaRetrospective cohort studyNeuroma AcousticMiddle AgedNeurovascular bundlemedicine.diseaseNeuromaFacial nerveMagnetic Resonance ImagingSensory SystemsSurgeryDissectionTreatment OutcomeOtorhinolaryngologyTranslabyrinthine approachFemaleNeurology (clinical)Facial Nerve DiseasesbusinessOtologic Surgical ProceduresFollow-Up StudiesOtologyneurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
researchProduct

Fabry disease: overall effects of agalsidase alfa treatment

2004

Background  Fabry disease is a rare X-linked disorder caused by deficient activity of the lysosomal enzyme α-galactosidase A. Progressive accumulation of the substrate globotriaosylceramide in cells throughout the body leads to major organ failure and premature death. The Fabry Outcome Survey (FOS) is a European outcomes database which was established to collect data on the natural history of this little-known disease and to monitor the long-term efficacy and safety of enzyme replacement therapy (ERT) with agalsidase alfa. This paper presents the first analysis of the FOS database on the effects of ERT on renal function, heart size, pain and quality of life. Design  The effects of 1 and 2 y…

AdultMalemedicine.medical_specialtyDatabases FactualClinical BiochemistryGlobotriaosylceramidePainRenal functionBiochemistrychemistry.chemical_compoundQuality of lifeInternal medicineHumansMedicineEnlarged heartBrief Pain Inventorybusiness.industryVascular diseaseMyocardiumGeneral MedicineEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry diseaseRecombinant ProteinsSurgeryIsoenzymesTreatment Outcomechemistryalpha-GalactosidaseQuality of LifeFabry DiseaseFemaleHypertrophy Left VentricularbusinessFollow-Up StudiesGlomerular Filtration RateEuropean Journal of Clinical Investigation
researchProduct

The Addition of an Immunosuppressant After Loss of Response to Anti-TNFα Monotherapy in Inflammatory Bowel Disease: A 2-Year Study

2018

Background The addition of an immunosuppressant (IM) after loss of response to anti-TNFα monotherapy is an emerging strategy of therapeutic optimization in patients with inflammatory bowel disease (IBD). However, few clinical data have been reported to date. We aimed to evaluate the efficacy and safety of this selective combination therapy in patients with IBD. Methods All consecutive patients with loss of response to anti-TNFα monotherapy despite an intensive dose optimization who added an IM from October 2014 to October 2016 were entered into a prospective database. Results Among 630 patients treated with anti-TNFα agents during the study period, 46 (7.3%) added an IM. A total of 31 patie…

AdultMalemedicine.medical_specialtyDatabases FactualCombination therapyGastroenterologyInflammatory bowel diseaseDrug Administration Schedule03 medical and health sciences0302 clinical medicineInternal medicinemedicineAdalimumabHumansImmunology and AllergyProspective StudiesAdverse effectbiologyTumor Necrosis Factor-alphabusiness.industryRemission InductionC-reactive proteinAdalimumabGastroenterologyAntibodies MonoclonalMiddle AgedInflammatory Bowel Diseasesmedicine.diseaseInfliximabGolimumabInfliximabDiscontinuationC-Reactive ProteinTreatment Outcome030220 oncology & carcinogenesisbiology.proteinDrug Therapy CombinationFemale030211 gastroenterology & hepatologybusinessImmunosuppressive Agentsmedicine.drugInflammatory Bowel Diseases
researchProduct

Monozygotic twinning after assisted reproductive technologies: a case report of asymmetric development and incidence during 19 years in an internatio…

2015

Objective To describe a case of monozygotic twinning with asymmetric development following a single fresh embryo transfer as part of an intracytoplasmic sperm injection (ICSI) treatment. Secondarily, to report the incidence of monozygotic twinning at the IVI (Instituto Valenciano de Infertilidad) clinics. Design Case report. Setting Private fertility centers. Patient(s) A 33-year-old woman with a 2-year history of primary infertility. Intervention(s) Controlled ovarian hyperstimulation and ICSI treatment with single-embryo transfer. Main Outcome Measure(s) Incidence of monozygotic twinning at the IVI clinics. Result(s) We report a twin pregnancy after a single-embryo transfer. Twins were di…

AdultMalemedicine.medical_specialtyDatabases FactualReproductive Techniques Assistedmedia_common.quotation_subjectmedicine.medical_treatmentFertilityReproductive technologyControlled ovarian hyperstimulationUltrasonography PrenatalIntracytoplasmic sperm injectionOvulation InductionPredictive Value of TestsPregnancySingle Embryo TransfermedicineHumansGenetic TestingSperm Injections IntracytoplasmicInfertility MaleTwin Pregnancymedia_commonGynecologyPregnancyIn vitro fertilisationTwinning Monozygoticbusiness.industryIncidence (epidemiology)Obstetrics and GynecologyTwins Monozygoticmedicine.diseaseFertilityTreatment OutcomeReproductive MedicinePregnancy TwinFemalebusinessLive BirthFertility and Sterility
researchProduct

The joint impact of donor and recipient parameters on the outcome of heart transplantation in Germany after graft allocation.

2013

Organ shortage in heart transplantation (HTx) results in increased use of grafts from donors with substantial risk factors. It is discussed controversially which donor characteristics may be detrimental. Therefore, we evaluated the joint impact of donor- and patient-related risk factors in HTx on patient survival by multiple analysis in a nationwide multicentre study after donor selection was carried out. The research database consists of data concerning hearts donated and transplanted in Germany between 2006 and 2008 as provided by Deutsche Stiftung Organtransplantation and the BQS Institute. Multiple Cox regression (significance level 5%, hazard ratio [95% CI]) was conducted (n = 774, rec…

AdultMalemedicine.medical_specialtyDatabases Factualmedicine.medical_treatmentDonor SelectionYoung AdultRisk FactorsInternal medicineGermanymedicineHumansCause of deathProportional Hazards ModelsHeart transplantationHeart FailureTransplantationbiologyProportional hazards modelDonor selectionbusiness.industryHazard ratioGraft SurvivalAge FactorsMiddle Agedmedicine.diseasePulmonary hypertensionTroponinSurvival AnalysisTissue DonorsSurgerymedicine.anatomical_structureTreatment OutcomeMultivariate AnalysisCardiologyVascular resistancebiology.proteinHeart TransplantationFemalebusinessTransplant international : official journal of the European Society for Organ Transplantation
researchProduct